• Our Solution
  • About
  • News and Press
  • Team
  • Use Cases
    • Emergency Medicine
    • Out of Hospital
UltraSight
  • UltraSight™ PVAD IQ Achieves Expert-Level Accuracy, Data Presented as Late-Breaking at THT 2026

    UltraSight

    March 3, 2026
    news, study, Recognition

    UltraSight™ PVAD IQ achieves a level of precision and consistency that meaningfully addresses one of the most technically challenging aspects of micro-axial flow pump management,

  • UltraSight™ Partners with Jefferson Health to Expand Access to Cardiac Imaging Through its Echo Stewardship Platform

    UltraSight

    January 7, 2026
    study

    Supported by the Israel Innovation Authority, the study aims to speed right-ventricular assessment in suspected pulmonary embolism TEL AVIV, ISRAEL AND PHILADELPHIA , PA, UNITED STATES, January 7, 2026 /EINPresswire.com/ — UltraSight™, a leader in AI-guided cardiac imaging workflows, today announced a partnership with Jefferson Health, one of the largest academic health systems in the United…

  • stanford study validates ultrasight

    Stanford RCT Validates UltraSight: Faster Scans, Better Imaging Quality, and Scalable Training

    UltraSight

    December 7, 2025
    study, news

    New clinical evidence from a Stanford University randomized controlled trial led by Dr. Andre Kumar demonstrates how UltraSight’s AI-guided cardiac ultrasound accelerates skill acquisition and improves imaging quality for clinicians with no prior echocardiography experience. In this peer-reviewed study, internal medicine residents using UltraSight with Philips Lumify achieved 43% faster cardiac scan acquisition, produced higher-quality…

One Broadway, 14th Floor
Cambridge MA 02142

info@ultrasight.com

Contact Us

Contact Us Global

Section

Section

Customer check

UltraSight is committed to protecting and respecting your privacy, and we’ll only use and process your personal information to respond to your message and as described in our Privacy Policy.

Privacy policy *

Occasionally, we would like to contact you by email about our products and services, as well as other content that may be of interest to you. You may unsubscribe from such emails via the link provided in the emails. If you consent to receive such emails from us, please tick below:

Marketing contact
  • LinkedIn
  • Twitter

Regulatory Approvals and Labeling

Patents

User Manual

Support

Privacy Policy

Terms and Conditions

Technical Specifications

UltraSight is a proud partner of Next October in commemorating victims of the 2023 Hamas War.

Read about Alon Kleinnman’s memorial

Design: Anzelevich Code: E&R © All copyright reserved to UltraSight

UltraSight is thrilled to announce that we have received FDA clearance for UltraSight AI Guidance

Read the full press release